Ting Fan

1.6k citations
28 papers · 1.2k indexed · 1 hit paper · h-index 15

Ting Fan

28 papers receiving 1.2k citations

Hit Papers

Therapeutic cancer vaccines: advancements, challenges and...278202320262024202550100150200250

Peers

Ting Fan
Comparison fields: 5 of 102
  • Pharmacology 179
  • Immunology 314
  • Complementary and alternative medicine 108
  • Pharmacology 164
  • Cancer Research 118
Replace Yeo Dae Yoon with:
Yeo Dae Yoon South Korea
Aning Sun China
Young–Jin Son South Korea
Xiaohui Wei China
Hui Guo China
Ju‐Hee Kang South Korea
Linzhong Yu China
Song‐Kyu Park South Korea
Shyr-Yi Lin Taiwan
Bethsebie Lalduhsaki Sailo India
Ting Fan relative to Yeo Dae Yoon South Korea Yeo Dae Yoon's profile →
Citations per field
00.5×9.4×
Yeo Dae Yoon · 1×
Citations per year

Countries citing papers authored by Ting Fan

Since Specialization
Citations

This map shows the geographic impact of Ting Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Fan more than expected).

Fields of papers citing papers by Ting Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Fan. The network helps show where Ting Fan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ting Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ting Fan Line = papers co-authored together Ting Fan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2
Therapeutic cancer vaccines: advancements, challenges and prospectsbreakdown →
2023278
3 20238
4 20222
5 20226
6 20214
7 202159
8 202035
9 202022
10 20208
11 2019106
12 20194
13 20174
14 201443
15 2013103
16 201332
17 2013113
18 201384
19 2012108
20 201278

About Ting Fan

Ting Fan is a scholar working on Complementary and alternative medicine, Pharmacology and Pharmacology, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Berberine and alkaloids research (8 papers), Andrographolide Research and Applications (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Mast cells and histamine (3 papers), Plant-based Medicinal Research (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Allergic Rhinitis and Sensitization (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Pharmacology (179 citations), Immunology (314 citations) and Complementary and alternative medicine (108 citations). Ting Fan has collaborated with scholars based in China and United States. Frequent co-authors include Xiaofeng Niu, Weifeng Li, Huimin Huang, Xing Wei, Chunyan Dong, Mingna Zhang, Jingxian Yang, Zhounan Zhu, Wanlu Cao and Yanmin Zhang. Their work appears in journals such as Genome biology, British Journal of Pharmacology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026